Health program participation in Halsnæs for people with diabetes, COPD, or heart disease
Official title: Effects for Individuals Following a Health Intervention Programme in Halsnaes Municipality; A Sub-project Under the Initiative: Quality Development in Community Healthcare: Steno Tvaers
Run by Steno Diabetes Center Copenhagen · NCT07641309 · Data updated 2026-11-12
This project tests whether a municipal health program in Halsnæs helps adults with diabetes, COPD, or cardiovascular disease participate more and stay engaged.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 194 (estimated) |
| Sponsor | Steno Diabetes Center Copenhagen Academic / other |
| Locations | 1 site (Frederiksværk) |
| Status | Recruiting |
| Started | May 28, 2026 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT07641309 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with type 2 diabetes, COPD, or cardiovascular disease who are offered a Halsnæs Municipality health program.
✕Probably not a fit
Individuals not enrolled in or offered the municipal health program may not experience any direct benefit from this sub-project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational sub-project is part of a cross-sector effort to adapt municipal health services for citizens with chronic diseases in Halsnæs. It aims to measure participation and retention in a local health program and to explore changes in functional ability over time. The study plans to enroll up to 200 eligible residents and use routine health records, registers, and interviews to describe the participant population and assess outcomes. Analyses include descriptive characterizations and comparisons of uptake before and after organizational changes under the Steno Tvaers initiative. The focus is on real-world implementation in a decentralized health care setting, with no specific interventions controlled by the study itself.
Why it matters
Potential benefit: If successful, the program could improve participation in municipal health services and support better management of chronic diseases.
How similar studies have gone: Previous initiatives in community health programs have shown improvements in engagement, though this exact, cross-sector model is relatively novel in Halsnæs.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of type 2 diabetes, chronic obstructive pulmonary disease, or cardiovascular disease * At or above 18 years of age * Offered a health programme provided by Halsnæs Municipality Exclusion Criteria: * None
Where it's running
-
Halsnæs Kommune
Frederiksværk, Denmark Recruiting
Study contacts
- Study coordinator: Stine V Hansen
- Email: stine.vest.hansen@regionh.dk
- Phone: +4524784580
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.